Can intravenous immunoglobulin improve antibody-mediated botulinum toxin therapy failure?

Movement Disorders

Volumn 15, Issue 6, 2000, Pages 1279-1281

  Dressler, Dirk ^a   Zettl, Uwe ^a   Benecke, Reiner ^a   Bigalke, Hans ^b  

^a UNIVERSITY OF ROSTOCK   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; BOTULINUM TOXIN A; DRUG ANTIBODY; IMMUNOGLOBULIN 7S; NEUTRALIZING ANTIBODY; VENIMMUN N;

ADULT; ANTIBODY PRODUCTION; ANTIBODY TITER; ARTICLE; CASE REPORT; DOSE RESPONSE; DRUG ANTIGENICITY; DRUG EFFECT; DRUG EFFICACY; DYSTONIA; HUMAN; IMMUNOADSORPTION; IMMUNOTHERAPY; MALE; PATIENT SATISFACTION; PRIORITY JOURNAL; SELF EVALUATION; SIDE EFFECT; TORTICOLLIS; TREATMENT FAILURE;

ADULT; BOTULINUM TOXIN TYPE A; DRUG THERAPY, COMBINATION; DRUG TOLERANCE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; MALE; NEUROMUSCULAR AGENTS; SEVERITY OF ILLNESS INDEX; TORTICOLLIS; TREATMENT FAILURE;

EID: 0033693191     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/1531-8257(200011)15:6<1279::AID-MDS1040>3.0.CO;2-4     Document Type: Article

References (21)

1. Long-term treatment of cervical dystonia with botulinum toxin A: Efficacy, safety, and antibody frequency
2. Depletion of neutralising antibodies resensitises a secondary non-responder to botulinum A neurotoxin
3. High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood
4. Immunomodulation in myasthenia gravis by high-dose intravenous 7-S immunoglobulins
5. Effects of intravenous immunoglobulin on muscle weakness and calcium-channel autoantibodies in the Lambert-Eaton myasthenic syndrome
6. High-dose intravenous immunoglobulin in the treatment of demyelinating neuropathy associated with monoclonal gammopathy
7. Multifocal motor neuropathy: Response to human immune globulin
8. Intravenous immunoglobulin treatment in patients with motor neuron syndromes associated with anti-GM1 antibodies: A double-blind, placebo-controlled study
9. Treatment of multifocal motor neuropathy with high dose intravenous immunoglobulins: A double blind, placebo controlled study
10. ANCA anti-idiotype antibodies and the treatment of systemic vasculitis with intravenous immunoglobulin
11. Idiotypy and idiotypic networks: A time to redefine concepts
12. Selectivity of recognition of variable (V) regions of autoantibodies by intravenous immunoglobulin (IVIg)
13. The Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS): Assessment of validity and inter-rater reliability
14. Botulinum A toxin: Neutralizing and nonneutralizing antibodies-therapeutic consequences
15. Botulinum toxin therapy failure: Causes, evaluation procedures and management strategies
16. Electromyographic quantification of the paralysing effect of botulinum toxin
17. The EBD test-a clinical test for the detection of antibodies to botulinum toxin type A
18. Observation on the isolated phrenic nerve diaphragm preparation in the rat
19. Tetanus toxin blocks the neuromuscular transmission in vitro like botulinum a toxin
20. Botulinum toxin anti-body testing: Comparison between the mouse diaphragm assay and the mouse lethality assay